Pharmaceuticals Industry Market Index
The Pharmaceuticals Industry in the Health Care Sector includes companies engaged in the research, development, or production of pharmaceuticals (including veterinary drugs).
The Pharmaceuticals industry index is a market composite index that includes 16 stocks from public trading companies and ADRs with the largest market capitalizations in the Pharmaceuticals industry.
The list of stocks in the Pharmaceuticals industry includes Zoetis Inc, Roche Holding AG, Novo Nordisk A/S, Sanofi, Catalent Inc, Glaxosmithkline PLC, Viatris Inc., Pfizer Inc, Merck & Co Inc, Eli Lilly and Co, Perrigo Co Plc, Novartis AG, Astrazeneca PLC, Johnson & Johnson, Roche Holding AG and Bristol-Myers Squibb Co.
5/7/2021 Health Care Sector Pharmaceuticals Industry
$14,490
Change: +0.92%
Open: $14,314
High: $14,546
Low: $14,397
| Zoetis Inc (ZTS) |
+2.41%
|
| Roche Holding AG (RHHBY) |
+2.08%
|
| Novo Nordisk A/S (NVO) |
+1.97%
|
| Sanofi (SNY) |
+1.59%
|
| Catalent Inc (CTLT) |
+1.30%
|
| Glaxosmithkline PLC (GSK) |
+1.16%
|
| Viatris Inc. (VTRS) |
+1.08%
|
| Pfizer Inc (PFE) |
+1.00%
|
| Pharmaceuticals Industry |
+0.92%
|
| Merck & Co Inc (MRK) |
+0.81%
|
| Eli Lilly and Co (LLY) |
+0.79%
|
| Perrigo Co Plc (PRGO) |
+0.73%
|
| Novartis AG (NVS) |
+0.70%
|
| Astrazeneca PLC (AZN) |
+0.62%
|
| Johnson & Johnson (JNJ) |
+0.45%
|
| Roche Holding AG (RHHBF) |
+0.00%
|
| Bristol-Myers Squibb Co (BMY) |
-0.03%
|
Index Value: $14,490 +0.92%
Volume: 1.61B Average Volume (3 month): 1.80B
Market Capitalization: $41.00T
EBITDA: $3.81T
EPS Basic: $169.71 Diluted: $160.81 Actual: $216.71
EPS Estimation: High $227.95 Medium: $210.69 Low: $197.50
EPS TTM: $381.16
P/E: 38.02
PEG Ratio (5 year Expected): 7.96
Dividend Yield: 5.73%
Dividend Rate: $818.53
Dividend Yield (Forward): 2.91%
Dividend Rate (Forward): $417.36
Shares Outstanding: 710.80B
Book Value: $2,668
Short Ratio: 3.08
Price Target (1 year): $14,769
Volume: 1.61B Average Volume (3 month): 1.80B
Market Capitalization: $41.00T
EBITDA: $3.81T
EPS Basic: $169.71 Diluted: $160.81 Actual: $216.71
EPS Estimation: High $227.95 Medium: $210.69 Low: $197.50
EPS TTM: $381.16
P/E: 38.02
PEG Ratio (5 year Expected): 7.96
Dividend Yield: 5.73%
Dividend Rate: $818.53
Dividend Yield (Forward): 2.91%
Dividend Rate (Forward): $417.36
Shares Outstanding: 710.80B
Book Value: $2,668
Short Ratio: 3.08
Price Target (1 year): $14,769
| Symbol | Security | Price | Gain | Volume | vol. Str. | Weight |
| ZTS | Zoetis Inc | 171.55 | +2.41% | 1.44M | 0.68 | 3.11% |
| RHHBY | Roche Holding AG | 42.13 | +2.08% | 1.26M | 0.76 | 11.03% |
| NVO | Novo Nordisk A/S | 75.66 | +1.97% | 737,763 | 0.78 | 6.59% |
| SNY | Sanofi | 51.82 | +1.59% | 2.16M | 1.16 | 4.90% |
| CTLT | Catalent Inc | 107.56 | +1.30% | 861,720 | 0.79 | 0.70% |
| GSK | Glaxosmithkline PLC | 38.35 | +1.16% | 2.59M | 0.45 | 3.63% |
| VTRS | Viatris Inc. | 14.08 | +1.08% | 10.59M | 1.00 | 0.65% |
| PFE | Pfizer Inc | 39.58 | +1.00% | 33.47M | 1.10 | 8.42% |
| Pharmaceuticals Industry | 14,489.98 | +0.92% | 1.61B | 0.90 | 42.84% | |
| MRK | Merck & Co Inc | 78.41 | +0.81% | 9.20M | 0.74 | 7.57% |
| LLY | Eli Lilly and Co | 195.42 | +0.79% | 2.28M | 0.66 | 7.15% |
| PRGO | Perrigo Co Plc | 42.96 | +0.73% | 735,613 | 0.56 | 0.22% |
| NVS | Novartis AG | 87.96 | +0.70% | 2.04M | 1.09 | 7.46% |
| AZN | Astrazeneca PLC | 53.81 | +0.62% | 4.76M | 0.46 | 5.38% |
| JNJ | Johnson & Johnson | 168.50 | +0.45% | 4.68M | 0.62 | 16.92% |
| RHHBF | Roche Holding AG | 370.00 | +0.00% | 100 | 0.46 | 10.81% |
| BMY | Bristol-Myers Squibb Co | 64.44 | -0.03% | 7.73M | 0.64 | 5.49% |
| Symbol | Security | Market Cap | EPS TTM | P/E | Div Yield | PEG Ratio |
| ZTS | Zoetis Inc | 81.493B | $3.71 | 46.24 | 0.48% | 3.20 |
| RHHBY | Roche Holding AG | 289.2B | N/A | N/A | 22.05% | |
| NVO | Novo Nordisk A/S | 172.795B | $2.90 | 26.09 | 12.26% | 101.69 |
| SNY | Sanofi | 128.433B | $5.26 | 9.85 | 6.27% | 1.83 |
| CTLT | Catalent Inc | 18.331B | $2.97 | 36.22 | 2.24 | |
| GSK | Glaxosmithkline PLC | 94.986B | $2.87 | 13.36 | 2.11% | 3.10 |
| VTRS | Viatris Inc. | 17.018B | -$0.59 | N/A | -1.06 | |
| PFE | Pfizer Inc | 220.616B | $1.50 | 26.39 | 3.90% | 0.72 |
| Pharmaceuticals Industry | $41.00T | $381.16 | 38.02 | 5.73% | 7.96 | |
| MRK | Merck & Co Inc | 198.327B | $2.76 | 28.41 | 3.19% | 1.32 |
| LLY | Eli Lilly and Co | 187.502B | $6.69 | 29.21 | 1.58% | 1.92 |
| PRGO | Perrigo Co Plc | 5.741B | -$1.21 | N/A | 2.11% | 1.62 |
| NVS | Novartis AG | 195.71B | $3.52 | 24.99 | 3.89% | 1.79 |
| AZN | Astrazeneca PLC | 141.086B | $0.96 | 56.05 | 5.24% | 1.08 |
| JNJ | Johnson & Johnson | 443.517B | $5.66 | 29.77 | 2.41% | 2.31 |
| RHHBF | Roche Holding AG | 283.431B | N/A | N/A | 2.46% | |
| BMY | Bristol-Myers Squibb Co | 143.951B | -$2.78 | N/A | 2.92% | 1.14 |
Back to Market Summary